Mary-Claire R Walsh, Mohammed Shafiul Alam, Kristen K Pierce, Marya Carmolli, Masud Alam, Dorothy M Dickson, Dan M Bak, Sajia Afreen, Forida Nazib, Kibria Golam, Firdausi Qadri, Sean A Diehl, Anna P Durbin, Stephen S Whitehead, Rashidul Haque, Beth D Kirkpatrick
BACKGROUND: Morbidity and mortality from dengue virus (DENV) is rapidly growing in the large populations of south Asia. Few formal evaluations of candidate dengue vaccine candidates have been undertaken in India, Pakistan, or Bangladesh. Tetravalent vaccines must be tested for safety and immunogenicity in all age groups and in those previously exposed and naive to DENV infections. TV005 is a live, attenuated tetravalent dengue vaccine. We evaluated the safety and immunogenicity of a single dose of TV005 across age groups in dengue-endemic Bangladesh...
September 27, 2023: Lancet Infectious Diseases